Textbook of Clinical Trials in Oncology: A Statistical Perspective at Meripustak

Textbook of Clinical Trials in Oncology: A Statistical Perspective

Books from same Author: Susan Halabi

Books from same Publisher: CRC Press

Related Category: Author List / Publisher List


  • Price: ₹ 11220.00/- [ 25.00% off ]

    Seller Price: ₹ 8415.00

Sold By: Store4Doctors      Click for Bulk Order

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

Free Shipping Available



Click for International Orders
  • Provide Fastest Delivery

  • 100% Original Guaranteed
  • General Information  
    Author(s)Susan Halabi
    PublisherCRC Press
    Edition1st
    ISBN9781138083776
    Pages626
    BindingHardcover
    LanguageEnglish
    Publish YearMay 2019

    Description

    CRC Press Textbook of Clinical Trials in Oncology: A Statistical Perspective by Susan Halabi

    There is an increasing need for educational resources for statisticians and investigators. Reflecting this, the goal of this book is to provide readers with a sound foundation in the statistical design, conduct, and analysis of clinical trials. Furthermore, it is intended as a guide for statisticians and investigators with minimal clinical trial experience who are interested in pursuing a career in this area. The advancement in genetic and molecular technologies have revolutionized drug development. In recent years, clinical trials have become increasingly sophisticated as they incorporate genomic studies, and efficient designs (such as basket and umbrella trials) have permeated the field. This book offers the requisite background and expert guidance for the innovative statistical design and analysis of clinical trials in oncology.

    Key Features:

    Cutting-edge topics with appropriate technical background
    Built around case studies which give the work a "hands-on" approach
    Real examples of flaws in previously reported clinical trials and how to avoid them
    Access to statistical code on the book’s website
    Chapters written by internationally recognized statisticians from academia and pharmaceutical companies
    Carefully edited to ensure consistency in style, level, and approach
    Topics covered include innovating phase I and II designs, trials in immune-oncology and rare diseases, among many others